title: Biopharmaceutical benchmarks 2006.
abstract: The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.
authors.affiliation: Industrial Biochemistry Programme, University of Limerick, Limerick, Ireland. gary.walsh@ul.ie
authors.forename: Gary
authors.initials: G
authors.lastname: Walsh
mesh_terms: D019985:Benchmarking; D017277:Drug Approval / Q000706:statistics & numerical data*; D016503:Drug Delivery Systems / Q000706:statistics & numerical data* / Q000639:trends; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000706:statistics & numerical data* / Q000639:trends; D005060:Europe; D006801:Humans; D030781:Organisms, Genetically Modified; D014481:United States